机译:政府补贴能够改善生物疾病补贴的合伙人,治疗脊柱胸腺炎的抗风湿剂:新加坡经验
Division of RheumatologyNational University Health SystemSingapore;
Division of RheumatologyNational University Health SystemSingapore;
Division of RheumatologyNational University Health SystemSingapore;
Department of Rheumatology and ImmunologySingapore General HospitalSingapore;
Department of Rheumatology Allergy and ImmunologyTan Tock Seng HospitalSingapore;
Division of RheumatologyNational University Health SystemSingapore;
Koh Wei Howe Arthritis &
Rheumatism Medical ClinicMount Elizabeth Medical CentreSingapore;
Department of MedicineKhoo Teck Puat HospitalSingapore;
Department of MedicineAlexandra Hospital (Jurong Health)Singapore;
Department of Rheumatology Allergy and ImmunologyTan Tock Seng HospitalSingapore;
Division of RheumatologyNational University Health SystemSingapore;
Koh Wei Howe Arthritis &
Rheumatism Medical ClinicMount Elizabeth Medical CentreSingapore;
Division of RheumatologyNational University Health SystemSingapore;
Leong Keng Hong Arthritis and Medical ClinicGleneagles Medical CentreSingapore;
ankylosing spondylitis; anti‐ TNF; biologics; government; spondyloarthritis; subsidy;
机译:政府补贴能够改善生物疾病补贴的合伙人,治疗脊柱胸腺炎的抗风湿剂:新加坡经验
机译:新加坡C第四次R R Huommatologists关于改性抗风湿剂治疗银屑病关节炎的政府补贴资格的达成声明
机译:新加坡C第四次R R Huommatologists关于改性抗风湿剂治疗银屑病关节炎的政府补贴资格的达成声明
机译:载有疾病修饰抗风湿药的多糖基纳米颗粒的治疗功效
机译:硝酸盐嵌合体:治疗阿尔茨海默氏病的新型疾病改良剂。
机译:类风湿关节炎和强直性脊柱炎患者接受生物疾病改良抗风湿药治疗后与估计的肾小球滤过率相关的危险因素
机译:磁共振断层扫描能力和管理治疗治疗疗效治疗的抗风药中的抗风药中的脊髓炎